Stéphane Paulus
MD, DTM&H, FRCPCH
Consultant in Paediatric Infectious Diseases
- Honorary Senior Lecturer in Paediatric Infectious Diseases
Bio
Stéphane is a consultant in paediatric infectious diseases at Oxford University Hospitals and an honorary senior lecturer at the University of Oxford. After medical training in Belgium, he trained in paediatrics in the US and in the UK. Stéphane was a fellow in paediatric infectious diseases in Vancouver, Canada from 2005 to 2008 and a consultant at Alder Hey Children’s Hospital, Liverpool, UK from 2010 to 2018. He joined the team in Oxford in 2018 and now leads the antimicrobial stewardship and the Infection Prevention and control activities at the Children’s Hospital. His research interests include antimicrobial studies and the use of biomarkers to enhance antimicrobial stewardship. Stéphane is the deputy director of the Postgraduate Diploma and the Masters in paediatric infectious diseases taught at the University. He was Secretary (2012-2016), then Convenor (2016-2020) of the British Paediatric Allergy, Immunity and Infection Group (BPAIIG).
Recent publications
Genetic determinants of the complement and coagulation pathways in invasive meningococcal disease.
Journal article
Bellos E. et al, (2025), J Allergy Clin Immunol, 156, 1743 - 1751.e4
Discharging Low-risk Neonates With Suspected Sepsis on Oral Antibiotics: An 18-Month Experience.
Journal article
Mandal H. et al, (2025), Pediatr Infect Dis J, 44, e478 - e479
Antifungal Prescribing in European Pediatric Intensive Care Units: Results of a Multinational 3-Month Weekly Point-Prevalence Survey†.
Journal article
Chorafa E. et al, (2025), J Pediatric Infect Dis Soc, 14
Immunity to Streptococcus pyogenes and Common Respiratory Viruses at Age 0 to 4 Years After COVID-19 Restrictions.
Journal article
Dokal K. et al, (2025), JAMA Netw Open, 8
Antifungal Use in Immunocompromised Children in Europe: A 12-Week Multicenter Weekly Point Prevalence Survey (CALYPSO).
Journal article
Chorafa E. et al, (2025), J Pediatr Hematol Oncol, 47, e222 - e230
A vaccine emergency – when to overrule parental refusal of vaccination at birth for prevention of vertical transmission of hepatitis B virus?
Journal article
Wilkinson D. and SAVULESCU J., (2025), Archives of Disease in Childhood
Effectiveness of biomarker-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection: the BATCH RCT.
Journal article
Waldron C-A. et al, (2025), Health Technol Assess, 29, 1 - 125
Severe Parvovirus B19-Associated Myocarditis in Children in the Post-COVID-19 Era: A Multicenter Observational Cohort Study.
Journal article
Russell N. et al, (2025), Open Forum Infect Dis, 12
A 5-transcript signature for discriminating viral and bacterial etiology in pediatric pneumonia.
Journal article
Viz-Lasheras S. et al, (2025), iScience, 28
Procalcitonin-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection in the UK (BATCH): a pragmatic, multicentre, open-label, two-arm, individually randomised, controlled trial.
Journal article
Waldron C-A. et al, (2025), Lancet Child Adolesc Health, 9, 121 - 130
A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatment.
Journal article
Viz-Lasheras S. et al, (2025), Nat Commun, 16
The impact of antimicrobial stewardship ward rounds on antimicrobial use and predictors of advice, uptake, and outcomes
Journal article
EYRE D. et al, (2025), Journal of Infection
Hot, swollen or stiff joints in children and young people: British Society for Rheumatology guideline scope.
Journal article
Bray L. et al, (2025), Rheumatol Adv Pract, 9
Vitamin D may influence disease course in PIMS-TS/MIS-C: An observational cohort study.
Journal article
Charlesworth JEG. et al, (2025), Pediatr Int, 67
Multiple introductions of NRCS-A Staphylococcus capitis to the neonatal intensive care unit drive neonatal bloodstream infections: a case-control and environmental genomic survey
Journal article
Lees E. et al, (2024), Microbial Genomics
Antifungal Drug Usage in European Neonatal Units: A Multicenter Weekly Point Prevalence Study.
Journal article
Chorafa E. et al, (2024), Pediatr Infect Dis J, 43, 1047 - 1048
Plasma Protein Biomarkers Distinguish Multisystem Inflammatory Syndrome in Children From Other Pediatric Infectious and Inflammatory Diseases.
Journal article
Yeoh S. et al, (2024), Pediatr Infect Dis J, 43, 444 - 453
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group ., (2024), Lancet Child Adolesc Health, 8, 190 - 200
The use of routinely collected electronic prescribing data to benchmark intravenous antibiotic use between two tertiary paediatric haematology-oncology inpatient units: a retrospective study.
Journal article
Channon-Wells S. et al, (2024), JAC Antimicrob Resist, 6